Ryan Moslin, Ph.D. - Bristol Myers Squibb
Ryan Moslin, Ph.D.
Principal Scientist, Oncology Chemistry
Central New Jersey
Ryan Moslin is one of Bristol Myers Squibb’s medicinal chemists, part of a team of scientists who use their knowledge of chemistry, biology and physiology to try to discover new treatments for diseases and other health problems.
As a principal scientist, Oncology Chemistry, Ryan works to develop small molecule therapies that will potentially treat immune-mediated diseases, which are illnesses often rooted in inflammation and can include cancer and arthritis. During his first five years at Bristol Myers Squibb, Ryan was instrumental in the discovery and development of an investigational treatment for various immune-mediated diseases, including plaque psoriasis, a condition that he himself lives with today. He continues to work towards new innovative medicines to treat additional autoimmune disorders.
“I think chemists in general are attracted to challenges, even unsolvable challenges. Some of us–and I see it with my coworkers–leap at the chance to do the hardest things,” he said. “I think you'll find most chemists don't believe there is anything that is unsolvable.”
Prior to joining Bristol Myers Squibb, Ryan worked as a post-doctoral associate at the Massachusetts Institute of Technology (MIT), where he studied materials science. He received a Ph.D. in organic chemistry from MIT, following a B.S. in honors chemistry from the University of British Columbia.
Ryan has been an author or presenter on more than 20 presentations, patents and publications.
Interests and Expertise
Having served as the co-chair of programs in early-phase oncology and immunology drug discovery at Bristol Myers Squibb, Ryan spends the bulk of his time uncovering new ways to modulate the immune system to treat disease. As a medicinal chemist, Ryan uses his chemistry background to design and build small molecules.
Ryan balances his work as a scientist with his role as a father and husband. He says the idea that he could discover a medicine that could help the next generation is part of the reason he enjoys coming to work every day.
“You come to work for the next generation, or more specifically, your next generation,” Moslin said. “It’s the idea that you can help, if not your child, then someone else’s child, even ten years down the road, and that someone else is working on something that may help my child.”
When not in the lab, he enjoys spending time with his wife and two daughters at their home in New Jersey, including assisting his girls with their homework or watching them figure skate and play ice hockey.